Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Gore

Showing results (101-110 of 215) with videos related to

Pageof 22
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomasYvette L Kasamon, Richard J Jones, Christopher D Gocke, et al.
Blood Advances|May 23, 2020
Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agentsSmith Giri, Scott F Huntington, Rong Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential ThrombocythemiaNikolai A Podoltsev, Mengxin Zhu, Amer M Zeidan, et al.
The Prostate|November 22, 2016
Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based StudyRong Wang, Amer M Zeidan, James B Yu, et al.
Blood Advances|October 19, 2018
The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia veraNikolai A Podoltsev, Mengxin Zhu, Amer M Zeidan, et al.
Haematologica|October 2, 2009
A phase 2 study of vorinostat in acute myeloid leukemiaEric W Schaefer, Arturo Loaiza-Bonilla, Mark Juckett, et al.
Cancer|June 10, 2011
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromesLewis R Silverman, Pierre Fenaux, Ghulam J Mufti, et al.
Cancer|August 6, 2019
Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United StatesSmith Giri, Weiwei Zhu, Rong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2017
Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of LifeRong Wang, Amer M Zeidan, Stephanie Halene, et al.
Oncotarget|February 11, 2017
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapyThomas Prebet, Andrea Toma, Thomas Cluzeau, et al.
Pageof 22

Showing results (101-110 of 215) with videos related to

Sort By:
Pageof 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomasYvette L Kasamon, Richard J Jones, Christopher D Gocke, et al.
Blood Advances|May 23, 2020
Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agentsSmith Giri, Scott F Huntington, Rong Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential ThrombocythemiaNikolai A Podoltsev, Mengxin Zhu, Amer M Zeidan, et al.
The Prostate|November 22, 2016
Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based StudyRong Wang, Amer M Zeidan, James B Yu, et al.
Blood Advances|October 19, 2018
The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia veraNikolai A Podoltsev, Mengxin Zhu, Amer M Zeidan, et al.
Haematologica|October 2, 2009
A phase 2 study of vorinostat in acute myeloid leukemiaEric W Schaefer, Arturo Loaiza-Bonilla, Mark Juckett, et al.
Cancer|June 10, 2011
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromesLewis R Silverman, Pierre Fenaux, Ghulam J Mufti, et al.
Cancer|August 6, 2019
Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United StatesSmith Giri, Weiwei Zhu, Rong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2017
Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of LifeRong Wang, Amer M Zeidan, Stephanie Halene, et al.
Oncotarget|February 11, 2017
Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapyThomas Prebet, Andrea Toma, Thomas Cluzeau, et al.
Pageof 22